NCT02192736 Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma Status UNKNOWN Phase PHASE1/PHASE2
NCT02190617 Guidelines to Practice: Reducing Asthma Health Disparities Through Guideline Implementation Status UNKNOWN Phase NA
NCT02189616 Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control Status UNKNOWN Phase NA
NCT02187445 Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial Status COMPLETED Phase PHASE1
NCT02182713 Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm Status COMPLETED Phase PHASE4
NCT02182700 Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis Status TERMINATED Phase PHASE3
NCT02182661 A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma Status COMPLETED Phase PHASE3
NCT02182505 Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma Status COMPLETED Phase PHASE3
NCT02182479 Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients Status COMPLETED Phase PHASE3
NCT02181335 Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy Status COMPLETED Phase PHASE3
NCT02177370 Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma Status TERMINATED Phase PHASE3
NCT02173795 Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition Status COMPLETED Phase PHASE3
NCT02170883 EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS Status COMPLETED Phase NA
NCT02169323 Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics Status COMPLETED Phase PHASE4
NCT02165046 Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. Status COMPLETED Phase PHASE1
NCT02165033 Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02163096 A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma Status COMPLETED Phase N/A